TrialThe Lancet. Oncology2021

Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study.

Mahrukh M Syeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.